Magnetic resonance imaging-derived parameters to predict response to regorafenib in recurrent glioblastoma. Martucci M, Ferranti AM, Schimperna F, Infante A, et al. Neuroradiology 2023 May 29. doi: 10.1007/s00234-023-03169.

Read + Share

Amedeo Smart

Independent Medical Education

Martucci M, Ferranti AM, Schimperna F, Infante A, et al. Magnetic resonance imaging-derived parameters to predict response to regorafenib in recurrent glioblastoma. Neuroradiology 2023 May 29. doi: 10.1007/s00234-023-03169.
PMID: 37247021